GLP-3RT 60mg

GLP3 is an investigational medication primarily being developed for the treatment of obesity and related metabolic disorders, including type 2 diabetes. It is a multi-receptor agonist that targets the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By activating these receptors, GLP3is thought to help regulate appetite, improve glucose metabolism, and promote weight loss.